Investigating the effect of Infliximab in women referred to Sina Hospital with anterior perianal fistula compared to surgical procedures

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

IRCT

Registry ID

IRCT20201113049373N2

Enrollment

Registered

2021-09-14

Start date

2019-03-21

Completion date

Unknown

Last updated

2021-11-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anterior fistula of peri-anal.

Interventions

Intervention group:.

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: Female patients with peri-anal anterior fistula

Exclusion criteria

Exclusion criteria: Active infection Severe heart failure Chronic infection Contra-indication of infilximab

Design outcomes

Primary

Measure	Time frame
Effect of infliximab in treatment of peri-anal anterior fistula. Timepoint: 0,14,42,180. Method of measurement: Questionnaire.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactEhsan Rahimpour

Tehran University of Medical Sciences

Dr.rahimpour83@yahoo.com+98 21 2163 0000

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026